Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites

CompletedOBSERVATIONAL
Enrollment

462

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Refractory Ascites
Interventions
PROCEDURE

transjugular intrahepatic portal shunt

TIPS was performed by experienced clinicians in the Gastroenterology/Hepatology Department according to standard operating procedures, utilizing 8 mm or 10 mm expanded polytetrafluoroethylene-covered stents at the discretion of the local physician.

Trial Locations (3)

710000

Tangdu hospital, Xi'an

Xi'an International Medical Center Hospital, Xi'an

Xijing hospital, Xi'an

All Listed Sponsors
lead

Tang-Du Hospital

OTHER

NCT06196723 - Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites | Biotech Hunter | Biotech Hunter